Literature DB >> 1811419

Immunologically activated cells in aural cholesteatoma.

V Schilling1, J Bujía, B Negri, P Schulz, E Kastenbauer.   

Abstract

In this immunohistochemical study, we characterized the cells infiltrating the stroma of acquired aural cholesteatomas in detail, using a panel of monoclonal antibodies directed against immune cell type-specific antigens, HLA class II antigens, and interleukin-2 receptor. For all antibodies used, normal ear skin was stained for comparison. The vast majority of the infiltrating cells was CD45-positive, ie, derived from bone marrow. Reactivity with anti-CD3 and anti-CD6 antibodies revealed an abundant infiltration of T lymphocytes beneath the squamous epithelium of cholesteatoma. The B lymphocyte-specific anti-CD19 and anti-CD22 antibodies detected only occasional positive cells. Hence, the cellular infiltrate in the stroma of aural cholesteatoma is made up primarily of T cells with macrophages scattered between them. Expression of HLA-DR was almost as high as that of CD45, whereas CD25-positive cells were detected in lower amounts. We infer that the majority of T cells and macrophages in the stroma of cholesteatoma are in an immunologically activated state. The characteristics of the infiltrating cell population suggest an antigen-driven process in cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1811419     DOI: 10.1016/0196-0709(91)90001-v

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  7 in total

1.  Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Authors:  J Bujia; H Sudhoff; A Holly; H Hildmann; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma.

Authors:  Bong Joon Jin; Hyun Jung Min; Jin Hyeok Jeong; Chul Won Park; Seung Hwan Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-05-31       Impact factor: 3.372

Review 3.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

4.  The Relationship between the M1/M2 Macrophage Polarization and the Degree of Ossicular Erosion in Human Acquired Cholesteatoma: An Immunohistochemical Study.

Authors:  Mohamed Bassiouni; Philipp Arens; Samira Ira Zabaneh; Heidi Olze; David Horst; Florian Roßner
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

5.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

Review 6.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

7.  Analysis of histopathological aspects in acquired middle ear cholesteatoma.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Fernando de Andrade Quintanilha Ribeiro; Jose Humberto Tavares Guerreiro Fregnani
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.